| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/19/2002 | EP1214400A2 Zymogen activation system |
| 06/19/2002 | EP1214347A2 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214326A1 Inhibitors of prenyl-protein transferase |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214323A1 Indoloazepines as vasopressin receptor antagonists |
| 06/19/2002 | EP1214322A2 Amino-triazolopyridine derivatives |
| 06/19/2002 | EP1214320A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1214313A2 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/19/2002 | EP1214312A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 06/19/2002 | EP1214302A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 06/19/2002 | EP1214299A1 Muscarinic antagonists |
| 06/19/2002 | EP1214298A2 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| 06/19/2002 | EP1214296A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/19/2002 | EP1214295A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/19/2002 | EP1214293A1 Non-peptidic cyclophilin binding compounds and their use |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214096A2 Taxane prodrugs |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214087A1 Combination treatment with il-1ra and compounds that inhibit il-1 processing and release |
| 06/19/2002 | EP1214064A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 06/19/2002 | EP1214062A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 06/19/2002 | EP1214041A2 Combination therapy for the treatment of sepsis |
| 06/19/2002 | EP1213975A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds |
| 06/19/2002 | EP1213971A1 Improving condition of elderly pets |
| 06/19/2002 | EP1165596B1 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 06/19/2002 | EP0975623B1 Indazole amide compounds as serotoninergic agents |
| 06/19/2002 | EP0941054B1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0892643B1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | EP0753302B1 Osteoporosis preventing or treating agent |
| 06/19/2002 | CN1354798A Process for preparation of pseudomonic acid A antibiotic by microbiological method |
| 06/19/2002 | CN1354750A Amine derivatives compounds |
| 06/19/2002 | CN1354749A Use of selective antagonists of 1b-adrenergic receptor for improvement of sexual dysfunction |
| 06/19/2002 | CN1354747A 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 06/19/2002 | CN1354744A Crystaline forms of sodium salt of 5-chloro-2-methoxy-N-(2(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide |
| 06/19/2002 | CN1354742A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/19/2002 | CN1354737A Novel derivatives of 3-3-diphenylpropylamines |
| 06/19/2002 | CN1354676A Amnotetralin derivative for therapy of cardiovascular diseases |
| 06/19/2002 | CN1354661A Novel method of treatment |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354014A Gongbu ointment |
| 06/19/2002 | CN1353990A Preparation for analgesia and anesthesia or curing drug dependence |
| 06/19/2002 | CN1353987A Medicine for curing myeloproliferative abnormal syndrome |
| 06/19/2002 | CN1086385C Methanesulphonate salt of arylpiperzine derived from tryptamine and its solvates for pharmaceutical use |
| 06/19/2002 | CN1086296C Compound donkey-hide gelatin preparation for preventing arrest of bone marrow in chemotherapy and radiotherapy and preparing method thereof |
| 06/18/2002 | US6407250 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists |
| 06/18/2002 | US6407244 Antiproliferative agent |
| 06/18/2002 | US6407239 Topoisomerase inhibitors |
| 06/18/2002 | US6407235 Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
| 06/18/2002 | US6407211 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/18/2002 | US6407135 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor |
| 06/18/2002 | US6407122 Neuroprotective agents, antiischemic, and hyperglycemic agents; huntington*s, parkinson*s, and alzheimer*s disease;amyotrophic lateral sclerosis treatment; nervous system and brain disorders |
| 06/18/2002 | US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/18/2002 | US6407110 Polyhydroxyalkylpyrazine derivatives and their preparation and medicines containing them |
| 06/18/2002 | US6407107 4-(morpholino)alkyl butanamide derivatives; autoimmune diseases; anticarcinogenic agents |
| 06/18/2002 | US6407106 For therapy of inflammatory disturbances of the gastrointestinal tract |
| 06/18/2002 | US6407104 Pyrrolo[1,2-a]pyrazine spla2 inhibitor |
| 06/18/2002 | US6407101 Progesterone receptor antagonists; contraceptives, hormone replacement therapy; breast and prostate cancer treatment; menopause |
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407093 (3,4-dihydro-2h-benzothiopyran-4-yl)-homopiperazine derivatives; antiischemic agents; alzheimer*s and parkinson*s disease, aids related dementia, multiple sclerosis, amyotrophic lateral sclerosis |
| 06/18/2002 | US6407088 Method of analgesia |
| 06/18/2002 | US6407086 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 06/18/2002 | US6407081 Administering azobisformamide or azobisformamidine derivative to inhibit interleukins, interferons and tumor necrosis factor |
| 06/18/2002 | US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 06/18/2002 | US6407070 Mixture containing granulation agent; therapy for kidney disease |
| 06/18/2002 | US6407067 Salts of thrombin inhibitors |
| 06/18/2002 | US6406865 Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodies |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406694 Anti-CCR2 antibodies |
| 06/18/2002 | US6406688 Method of treating sepsis and ARDS with chemokine β-4 |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | CA2356812A1 Tnf-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/18/2002 | CA2241725C Growth-hormone secretagogues |
| 06/18/2002 | CA2235053C Novel amino compounds of 6,7,8,9-tetrahydro-cyclopenta[a]naphthalene and 2,3-dihydro-cyclopenta[e]indene, process for their preparation and pharmaceutical compositions containing them |
| 06/18/2002 | CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace |
| 06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 06/14/2002 | WO2001041709A2 Methods for treating cell death diseases and inflammation |
| 06/14/2002 | CA2393722A1 Methods for treating cell death diseases and inflammation |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046461A2 Method for identifying modulators of transcription |
| 06/13/2002 | WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046423A2 Protein derived from the melanin-concentrating hormone (mch), corresponding nucleic acids and their use for preparing medicines |
| 06/13/2002 | WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046412A2 Regulation of angiogenesis with zinc finger proteins |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |